GlassScriptPhysician profile
Banveet Kaur
NPI 1265994339
$6,055.19
in general payments reported to CMS, 2019-2025
15 companies · $4,030 in 2025
The $4,030 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $325 · 2024: $1,700 · 2025: $4,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,560 · Travel and Lodging: $2,139 · Education: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,559.88 |
| Travel and Lodging | $2,138.83 |
| Education | $356.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,302.31 | 2023-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Biotronik INC. | $1,669.44 | 2025 | Acticor 7 Vr-T Dx |
| Abiomed | $545.98 | 2024 | Impella |
| Shockwave Medical, INC | $358.95 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $279.23 | 2024-2025 | Aurora Ev-Icd Mri Surescan, Micra |
| Biosense Webster, INC. | $275.29 | 2024 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Astellas Pharma US INC | $198.99 | 2023 | |
| Edwards Lifesciences Corporation | $99.54 | 2024 | Hemosphere |
| E.R. Squibb & Sons, L.L.C. | $78.91 | 2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $63.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.01 | 2023-2024 | Jardiance |
| Lantheus Medical Imaging, INC. | $40.42 | 2024 | |
| Kestra Medical Technology Services, INC. | $38.38 | 2025 | Assure Wcd |
| Pfizer INC. | $25.58 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $24.16 | 2024 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Banveet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.